News

Dementia usually affects older people, so when it occurs in middle age, it can be hard to recognize. The most common form is frontotemporal dementia (FTD), which is often mistaken for depression, ...
Kids to Love is partnering with iXpressGenes (iXG) in kickstarting a new clinical trial aimed at addressing PTSD through ...
An international research team has discovered a critical protein that acts as a 'switch' regulating immune responses to viruses.
Adam Kovalčík figured out how to make an antiviral drug for a fraction of the normal cost, using an alcohol from corn husks.
The RNP complex is the influenza virus’s essential package, the virus’s blueprints and a copy machine all rolled in one. The ...
An article published on a medical website Medscape Today was entitled “Minnesota Bill Against Vaccines Promotes ...
Researchers characterized pathogens associated with infectious uveitis using conventional diagnostics and metagenomic sequencing in intraocular fluid samples.
The deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.
Approximately 30% of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that ...
The firm announced deals with UMass Chan Medical School and Quiver to further its ambitions to develop transformative treatments for the condition.
Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...
Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.